Purdue Puts Forth FDA Decisions As Defense To Massachusetts Opioid Suit
Purdue says Commonwealth is trying to hold it liable for conduct FDA has authorized; citing agency's approval of long-term use of OxyContin for chronic pain, company asks court to dismiss complaint.
You may also be interested in...
Company is paying nearly $200m for an Oklahoma State University endowment, $12.5m to abate effects of opioid crisis and $60m for litigation costs.
Exec was worried Richard Sackler's visits could prompt complaints to FDA's Bad Ad Program; complaint alleges deceptive actions by Purdue execs to boost opioid prescriptions.
Bellwether trial set to begin in September after judge says cities may be able to recover damages for cost of governmental services that are the result of defendants' alleged conduct.